Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This study is a double-blind placebo-controlled trial evaluating the efficacy of raloxifene
in the prevention of bone mineral density loss in patients receiving long term
corticosteroids.